Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-Inferiority Study on MRNA-lncRNA Model in Low-Risk Triple-Negative Breast Cancer Patients

NCT06795503 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT06795503
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06795503 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-Inferiority Study on MRNA-lncRNA Model in Low-Risk Triple-Negative Breast Cancer Patients
Lead sponsor
Fudan University
Phase
Phase 3
Overall status
Not yet recruiting
Start date
February 28, 2025
Completion date
July 31, 2031
Enrollment
1,462 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

triple-negative breast cancer